Increased CRP levels and monocyte activity in type 1 diabetes

被引：0
|
作者：
Devaraj, S
Glaser, N
Griffen, S
Wang-Polagruto, J
Jialal, I
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 50 条
  • [31] Increased Hemoglobin AGE Levels in Type 1 Diabetes Patients and Correlation With Vascular Inflammation
    Januszewski, Andrzej S.
    Calandro, Daniel
    O'Neal, David N.
    Karschimkus, Connie S.
    Jenkins, Alicia J.
    DIABETES, 2012, 61 : A157 - A157
  • [32] Physical Activity Levels of Adolescents with Type 1 Diabetes Physical Activity in T1D
    de Lima, Valderi Abreu
    Gomes Mascarenhas, Luis Paulo
    Decimo, Juliana Pereira
    de Souza, William Cordeiro
    Stellfeld Monteiro, Anna Louise
    Lahart, Ian
    Franca, Suzana Nesi
    Leite, Neiva
    PEDIATRIC EXERCISE SCIENCE, 2017, 29 (02) : 213 - 219
  • [33] Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus
    Harding, SA
    Sommerfield, AJ
    Sarma, J
    Twomey, PJ
    Newby, DE
    Frier, BM
    Fox, KAA
    ATHEROSCLEROSIS, 2004, 176 (02) : 321 - 325
  • [34] Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
    Fosmark, Dag S.
    Berg, Jens P.
    Jensen, Aase-Brith
    Sandvik, Leiv
    Agardh, Elisabet
    Agardh, Carl-David
    Hanssen, Kristian F.
    ACTA OPHTHALMOLOGICA, 2009, 87 (05) : 498 - 500
  • [35] Increased sVCAM-1 levels are associated with micro- and macrovascular complications in type 1 diabetes
    Soedamah-Muthu, SS
    Chaturvedi, N
    Schalkwijk, CG
    Fuller, JH
    Stehouwer, CDA
    DIABETES, 2001, 50 : A167 - A167
  • [36] Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes
    Beyan, Huriya
    Goodier, Martin R.
    Nawroly, Niga S.
    Hawa, Mohammed I.
    Bustin, Stephen A.
    Ogunkolade, William B.
    Londei, Marco
    Yousaf, Nasim
    Leslie, R. David G.
    DIABETES, 2006, 55 (12) : 3439 - 3445
  • [37] Increased levels of nitrosylated protein in Type I diabetes mellitus
    Milsom, AB
    Jones, CJH
    Goodfellow, J
    Frenneaux, MP
    Peters, JR
    James, PE
    FASEB JOURNAL, 2002, 16 (04): : A433 - A434
  • [38] Increased Aldosterone Levels in a Model of Type 2 Diabetes Mellitus
    Fredersdorf, S.
    Endemann, D. H.
    Luchner, A.
    Heitzmann, D.
    Ulucan, C.
    Birner, C.
    Schmid, P.
    Stoelcker, B.
    Resch, M.
    Muders, F.
    Riegger, G. Aj
    Weill, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (01) : 15 - 20
  • [39] Increased procarboxypeptidase U levels in type II diabetes.
    Van Gaal, L
    Schatteman, K
    Goossens, F
    Mertens, I
    Scharpé, S
    De Leeuw, I
    Hendriks, D
    DIABETOLOGIA, 1999, 42 : A23 - A23
  • [40] Serum levels of hydroimidazolone are increased in retinopathy of Type 2 diabetes
    Fosmark, DS
    Torjesen, PA
    Kilhovd, B
    Berg, TJ
    Sandvik, L
    Hanssen, KF
    Agardh, CD
    Agardh, E
    DIABETOLOGIA, 2004, 47 : A451 - A452
12345